Corbus Pharmaceuticals (CRBP) Stock: Taking A Dive On False Rumor


Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP)

Corbus Pharmaceuticals Holdings was off to a relatively strong start to the trading session today. However, that all changed minutes ago as the stock started to take a dive. Below, we’ll talk about what we’re seeing from the stock, why, and what we’ll be watching for with regard to CRBP moving forward.

What We’re Seeing From CRBP

As mentioned above, Corbus Pharmaceuticals Holdings was off to a relatively strong start in the market today. When the opening bell rang, the stock started moving toward the top and stayed well into the green throughout most of the trading session. However, minutes ago, we started to see a big spike downward, bringing the stock well into the red. At the moment (12:54), CRBP is trading at $8.00 per share after a loss of $0.15 per share (1.84%) thus far today.

Why The Stock Is Falling

As usual, as soon as we noticed the decline in value on CRBP, the CNA Finance team went to work to dig up the cause for the drop. It didn’t take long to find the news, and, unfortunately, it wasn’t positive.

There are reports in social media that EMA status has been declined. The company hasn’t had the data to apply for this status. So the rumor cannot be true. Now that they do however, they will likely do so soon.

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on CRBP for plans associated with moving forward. Maybe EMA Prime Status will be achieved, and the company will go back to business as usual. Nonetheless, we’ll keep an eye on the news and bring it to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required

[adrotate group=”4″]

[Image Courtesy of Wikimedia]


Please enter your comment!
Please enter your name here